Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
Evolent Health (NYSE:EVH), a healthcare company focused on complex conditions management, has scheduled its Q2 2025 earnings release for August 7, 2025, after market close. The company will host a conference call at 5:00 PM ET the same day.
Shareholders can access the live broadcast through Evolent's investor relations website. Analysts can participate by dialing 855.940.9467 (US) or 412.317.6034 (International). Additionally, EVH's management team will present at the Canaccord Genuity 44th Annual Growth Conference in Boston on August 13, 2025.
Evolent Health (NYSE:EVH), un'azienda sanitaria specializzata nella gestione di condizioni complesse, ha programmato la pubblicazione dei risultati del secondo trimestre 2025 per il 7 agosto 2025, dopo la chiusura del mercato. La societ脿 terr脿 una conference call alle 17:00 ET dello stesso giorno.
Gli azionisti potranno seguire la trasmissione in diretta tramite il sito web delle relazioni con gli investitori di Evolent. Gli analisti potranno partecipare chiamando il numero 855.940.9467 (USA) o 412.317.6034 (internazionale). Inoltre, il team di gestione di EVH presenter脿 al Canaccord Genuity 44掳 Annual Growth Conference a Boston il 13 agosto 2025.
Evolent Health (NYSE:EVH), una empresa de salud enfocada en la gesti贸n de condiciones complejas, ha programado la publicaci贸n de sus resultados del segundo trimestre de 2025 para el 7 de agosto de 2025, tras el cierre del mercado. La compa帽铆a realizar谩 una llamada conferencia a las 5:00 PM ET ese mismo d铆a.
Los accionistas podr谩n acceder a la transmisi贸n en vivo a trav茅s del sitio web de relaciones con inversores de Evolent. Los analistas pueden participar llamando al 855.940.9467 (EE.UU.) o al 412.317.6034 (internacional). Adem谩s, el equipo directivo de EVH presentar谩 en la 44陋 Conferencia Anual de Crecimiento de Canaccord Genuity en Boston el 13 de agosto de 2025.
Evolent Health (NYSE:EVH)電� 氤奠灐頃� 歆堩櫂 甏�毽棎 欷戩爯鞚� 霊� 項姢旒�鞏� 旮办梾鞙茧, 2025雲� 2攵勱赴 鞁れ爜 氚滍憸毳� 2025雲� 8鞗� 7鞚� 鞛� 毵堦皭 頉勳棎 鞓堨爼頃橁碃 鞛堨姷雼堧嫟. 須岇偓電� 臧欖潃 雮� 霃欕秬 響滌鞁� 鞓ろ泟 5鞁�鞐� 旎嵓霟办姢 旖滌潉 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
欤检＜霌れ潃 Evolent鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 靸濎瓿勳棎 鞝戩啀頃� 靾� 鞛堨姷雼堧嫟. 鞎犽剱毽姢韸鸽摛鞚� 氙戈淡 雮� 855.940.9467 霕愲姅 甑牅 鞝勴檾 412.317.6034搿� 鞝勴檾頃� 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 霕愴暅 EVH 瓴届榿歆勳潃 2025雲� 8鞗� 13鞚� 氤挫姢韯挫棎靹� 鞐措Μ電� Canaccord Genuity 鞝�44須� 鞐半 靹膘灔 旎嵓霟办姢鞐愳劀 氚滍憸頃� 鞓堨爼鞛呺媹雼�.
Evolent Health (NYSE:EVH), une entreprise de sant茅 sp茅cialis茅e dans la gestion des conditions complexes, a pr茅vu la publication de ses r茅sultats du deuxi猫me trimestre 2025 pour le 7 ao没t 2025, apr猫s la cl么ture des march茅s. La soci茅t茅 organisera une conf茅rence t茅l茅phonique 脿 17h00 ET le m锚me jour.
Les actionnaires pourront acc茅der 脿 la diffusion en direct via le site des relations investisseurs d'Evolent. Les analystes peuvent participer en composant le 855.940.9467 (脡tats-Unis) ou le 412.317.6034 (international). De plus, l'茅quipe de direction d'EVH pr茅sentera lors de la 44e conf茅rence annuelle de croissance Canaccord Genuity 脿 Boston le 13 ao没t 2025.
Evolent Health (NYSE:EVH), ein auf die Behandlung komplexer Erkrankungen spezialisiertes Gesundheitsunternehmen, hat die Ver枚ffentlichung der Ergebnisse f眉r das zweite Quartal 2025 f眉r den 7. August 2025 nach B枚rsenschluss geplant. Am selben Tag wird das Unternehmen um 17:00 Uhr ET eine Telefonkonferenz abhalten.
Aktion盲re k枚nnen die Live-脺bertragung 眉ber die Investor-Relations-Website von Evolent verfolgen. Analysten k枚nnen teilnehmen, indem sie die Nummer 855.940.9467 (USA) oder 412.317.6034 (international) w盲hlen. Dar眉ber hinaus wird das Management von EVH am 44. j盲hrlichen Wachstumskonferenz von Canaccord Genuity in Boston am 13. August 2025 teilnehmen und pr盲sentieren.
- None.
- None.
Company to Participate in Upcoming Conferences
Shareholders and interested participants may listen to a live broadcast of the conference call found on听Evolent's investor relations website, .
Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.
An audio playback of the conference call will be available on Evolent's investor relations website for 90 days after the call.
Upcoming Investor Events
Additionally, Evolent announced that its executive management team will participate in upcoming investor conferences.
A live audio-only webcast and replay for these events will be available on the "Events and Presentations" section of Evolent's investor relations website. Presentation webcast times will be posted on the website as they become available.
- Canaccord Genuity 44th Annual Growth Conference at the Intercontinental Boston in
Boston, Massachusetts on August 13, 2025
About Evolent
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting .
Contacts:
[email protected]
听
View original content to download multimedia:
SOURCE Evolent Health, Inc.
FAQ
When will Evolent Health (EVH) release Q2 2025 earnings?
How can investors access Evolent Health's Q2 2025 earnings call?
How long will Evolent Health's Q2 2025 earnings call replay be available?
Where is Evolent Health presenting in August 2025?
